Shigeru Miki

1.1k citations

20 papers · 879 indexed · h-index 13

Co-authors: Akihiko Sato Tamio Fujiwara Takahiro Seki Chiaki Wakasa-Morimoto Tomokazu Yoshinaga Mark Underwood Masanori Kobayashi Edward P. Garvey
Topics: HIV Research and Treatment (17 papers)HIV/AIDS drug development and treatment (14 papers)HIV/AIDS Research and Interventions (7 papers)
Cited by: Virology Infectious Diseases Molecular Biology
Journals: Antimicrobial Agents and Chemotherapy Virology Carbohydrate Research
Partner nations: Japan United States

In The Last Decade

Shigeru Miki

19 papers receiving 856 citations

Peers

Countries citing papers authored by Shigeru Miki

Since Specialization

Citations

This map shows the geographic impact of Shigeru Miki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeru Miki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeru Miki more than expected).

Fields of papers citing papers by Shigeru Miki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeru Miki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeru Miki. The network helps show where Shigeru Miki may publish in the future.

Co-authorship network of co-authors of Shigeru Miki

This figure shows the co-authorship network connecting the top 25 collaborators of Shigeru Miki. A scholar is included among the top collaborators of Shigeru Miki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeru Miki. Shigeru Miki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Molecular design and evaluation of aza-polycyclic carbamoyl pyridones as HIV-1 integrase strand transfer inhibitors 2024 ·Bioorganic & Medicinal Chemistry Letters ·Toshiyuki Akiyama,Brian A. Johns,Yoshiyuki Taoda,Hiroshi Yoshida,Teruhiko Taishi,Takashi Kawasuji,Hitoshi Murai,Tomokazu Yoshinaga,Akihiko Sato,Takahiro Seki,(unknown),Shigeru Miki,(unknown),(unknown),Tamio Fujiwara	3
2	Barrier to Resistance of Dolutegravir in Two-Drug Combinations 2019 ·Antimicrobial Agents and Chemotherapy ·Tomokazu Yoshinaga,Shigeru Miki,(unknown),Takahiro Seki,Tamio Fujiwara	10
3	Novel secondary mutations C56S and G149A confer resistance to HIV-1 integrase strand transfer inhibitors 2018 ·Antiviral Research ·Tomokazu Yoshinaga,Takahiro Seki,Shigeru Miki,Tadashi Miyamoto,(unknown),(unknown),Masanori Kobayashi,Akihiko Sato,Eugene L. Stewart,Mark Underwood,Tamio Fujiwara	17
4	Effects of Raltegravir or Elvitegravir Resistance Signature Mutations on the Barrier to Dolutegravir Resistance In Vitro 2015 ·Antimicrobial Agents and Chemotherapy ·Takahiro Seki,(unknown),(unknown),Shigeru Miki,Chiaki Wakasa-Morimoto,(unknown),Koichiro Nakahara,Masanori Kobayashi,Mark Underwood,Akihiko Sato,Tamio Fujiwara,Tomokazu Yoshinaga	32
5	Antiviral Characteristics of GSK1265744, an HIV Integrase Inhibitor Dosed Orally or by Long-Acting Injection 2014 ·Antimicrobial Agents and Chemotherapy ·Tomokazu Yoshinaga,Masanori Kobayashi,Takahiro Seki,Shigeru Miki,Chiaki Wakasa-Morimoto,(unknown),(unknown),Teruhiko Taishi,Takashi Kawasuji,Brian A. Johns,Mark Underwood,Edward P. Garvey,Akihiko Sato,Tamio Fujiwara	83
6	In VitroAntiretroviral Properties of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor 2010 ·Antimicrobial Agents and Chemotherapy ·Masanori Kobayashi,Tomokazu Yoshinaga,Takahiro Seki,Chiaki Wakasa-Morimoto,Kevin Brown,Robert G. Ferris,Scott A. Foster,Richard Hazen,Shigeru Miki,(unknown),(unknown),Teruhiko Taishi,Takashi Kawasuji,Brian A. Johns,Mark Underwood,Edward P. Garvey,Akihiko Sato,Tamio Fujiwara	317
7	Secondary mutations in viruses resistant to HIV-1 integrase inhibitors that restore viral infectivity and replication kinetics 2008 ·Antiviral Research ·Koichiro Nakahara,Chiaki Wakasa-Morimoto,Masanori Kobayashi,Shigeru Miki,Takeshi Noshi,Takahiro Seki,(unknown),(unknown),(unknown),Toshio Fujishita,Tomokazu Yoshinaga,Edward P. Garvey,Brian A. Johns,Scott A. Foster,Mark Underwood,Akihiko Sato,Tamio Fujiwara	46
8	Selection of diverse and clinically relevant integrase inhibitor-resistant human immunodeficiency virus type 1 mutants 2008 ·Antiviral Research ·Masanori Kobayashi,Koichiro Nakahara,Takahiro Seki,Shigeru Miki,(unknown),(unknown),Chiaki Wakasa-Morimoto,Makoto Kodama,(unknown),(unknown)	91
9	A single amino acid change at Leu-188 in the reverse transcriptase of HIV-2 and SIV renders them sensitive to non-nucleoside reverse transcriptase inhibitors 2001 ·Archives of Virology ·Yoshitaka Isaka,Shigeru Miki,(unknown),(unknown),(unknown),Akio Adachi,Tomoyuki Miura,Masanori Hayami,Osamu Yoshie,Tamio Fujiwara,Akihiko Sato	25
10	Isolation and characterization of simian immunodeficiency virus variants that are resistant to nonnucleoside reverse transcriptase inhibitors 2000 ·Archives of Virology ·Yoshitaka Isaka,Shigeru Miki,(unknown),(unknown),(unknown),Akio Adachi,Masanori Hayami,Osamu Yoshie,Tamio Fujiwara,Akihiko Sato	6
11	Small Amino Acid Changes in the V3 Loop of Human Immunodeficiency Virus Type 2 Determines the Coreceptor Usage for CXCR4 and CCR5 1999 ·Virology ·Yoshitaka Isaka,Akihiko Sato,Shigeru Miki,(unknown),(unknown),Toshiyuki Hori,Takashi Uchiyama,Akio Adachi,Masanori Hayami,Tamio Fujiwara,Osamu Yoshie	42
12	Enhanced HIV-1 Replication by Chemokines Constitutively Expressed in Secondary Lymphoid Tissues 1999 ·Virology ·Morio Nagira,Akihiko Sato,Shigeru Miki,Toshio Imai,Osamu Yoshie	21
13	Structural determination of metabolites of S-1153, a new, potent, non-nucleoside, anti-HIV agent in rat liver microsomes 1998 ·Xenobiotica ·(unknown),Satoru Goto,Shigeru Miki,Akihiko Sato,Takeshi Kuroda,(unknown),Michiko Takeuchi,Masakazu Nakano	6
14	S-1153 Inhibits Replication of Known Drug-Resistant Strains of Human Immunodeficiency Virus Type 1 1998 ·Antimicrobial Agents and Chemotherapy ·Tamio Fujiwara,Akihiko Sato,(unknown),Shigeru Miki,Kenji Abe,Yoshitaka Isaka,Makoto Kodama,(unknown),Lan Bo Chen,Hiroshi Harada,Hirohiko Sugimoto,Masakazu Hatanaka,Yorio Hinuma	110
15	Construction of the Chimeric Reverse Transcriptase of Simian Immunodeficiency Virus Sensitive to Nonnucleoside Reverse Transcriptase Inhibitor 1998 ·Microbiology and Immunology ·Yoshitaka Isaka,Akihiko Sato,(unknown),(unknown),Shigeru Miki,Masanori Hayami,Tamio Fujiwara	8
16	Evidence for Direct Association of Vpr and Matrix Protein p17 within the HIV-1 Virion 1996 ·Virology ·Akihiko Sato,(unknown),Yoshitaka Isaka,Shigeru Miki,(unknown),Akio Adachi,Masanori Hayami,Tamio Fujiwara,Osamu Yoshie	26
17	Synthesis of the 4-, 6-deoxy, and 4,6-dideoxy derivatives of d-mannose 1996 ·Carbohydrate Research ·Toshiyuki Nishio,(unknown),Koji Kubota,(unknown),Shigeru Miki,Teiichirô Ito,Tadatake Oku	18
18	A simple and rapid method for preliminary evaluation of in vivo efficacy of anti-HIV compounds in mice 1995 ·Antiviral Research ·Akihiko Sato,Makoto Kodama,Kenji Abe,Shigeru Miki,(unknown),(unknown),Masaru Ogata,Tatsuo Toyoda,Hirohiko Sugimoto,Osamu Yoshie,Tamio Fujiwara	14
19	Functionalized amino acid complexation to a cobalt(III) complex of (2R,5R,8R,11R)-2,5,8,11-tetraethyl-1,4,7,10-tetra-azacyclododecane. Crystal structures of complexes containing (R)- or (S)-serine and (R)-α-methylserine, and release of amino acid from the complexes 1989 ·Journal of the Chemical Society Dalton Transactions ·Sei Tsuboyama,Shigeru Miki,(unknown),(unknown),Tosio Sakurai	3
20	A carbonato(optically active cyclen)cobalt(III) complex 1989 ·Acta Crystallographica Section C Crystal Structure Communications ·Sei Tsuboyama,Shigeru Miki,Kôji Kobayashi,(unknown),Tosio Sakurai	1

About Shigeru Miki

Shigeru Miki is a scholar working on Virology, Infectious Diseases and Biochemistry, having authored 20 papers that have together received 879 indexed citations. Recurring topics across this work include HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (14 papers) and HIV/AIDS Research and Interventions (7 papers). The work is most often cited by research in Virology (733 citations), Infectious Diseases (774 citations) and Molecular Biology (299 citations). Shigeru Miki has collaborated with scholars based in Japan and United States. Frequent co-authors include Akihiko Sato, Tamio Fujiwara, Takahiro Seki, Chiaki Wakasa-Morimoto, Tomokazu Yoshinaga, Mark Underwood, Masanori Kobayashi, Edward P. Garvey, Brian A. Johns and Takashi Kawasuji. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Virology and Carbohydrate Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact